^○Takahiro MASUDA¹, Tadafumi KATO², Jun ISHIGOOKA³, Kei WATABE¹, Mari MIYAJIMA¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. RIKEN Brain Science Institute, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Takahiro MASUDA¹, Jun ISHIGOOKA², Tadafumi KATO³, Kei WATABE¹, Mari MIYAJIMA¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. Institute of CNS Pharmacology, Japan, 3. RIKEN Brain Science Institute, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Jun ISHIGOOKA¹, Tadafumi KATO², Mari MIYAJIMA³, Kei WATABE³, Takahiro MASUDA³, Teruhiko HIGUCHI^{4, 5} (1. Institute of CNS Pharmacology, Japan, 2. RIKEN Brain Science Institute, Japan, 3. Sumitomo Dainippon Pharma Co., Ltd., Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

^○Yen-Feng LIN¹, Shih-Ku LIN^{2, 3} (1. Balance Psychiatric Clinic, Hsinchu City, Taiwan, 2. Department of Psychiatry, Taipei City Hospital and Psychiatric Center, Taipei City, Taiwan, 3. Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei City, Taiwan)

^○Nak-Young KIM, Young Sup WOO, Won-Myong BAHK (Department of Psychiatry, The Catholic University of Korea )

^○Kunihiro IWAMOTO¹, Akiko YAMAGUCHI¹, Masahiko ANDO², Kiyoshi FUJITA³, Motonori YOKOYAMA⁴, Tsuyoshi AKIYAMA⁵, Yoshio IGARASHI⁶, Reiji YOSHIMURA⁷, Norio OZAKI¹ (1. Department of Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan, 2. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Aichi, Japan, 3. Department of Psychiatry, Okehazama Hospital, Aichi, Japan, 4. Sapporo Ekimae Clinic, Sapporo, Japan, 5. Department of Psychiatry, NTT Medical Center Tokyo, Tokyo, Japan, 6. Medical Care Toranomon, Tokyo, Japan, 7. Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan)

^○Fumitaka NAKANO¹, Kyosuke UNO^{2, 3}, Kazuki TOKORO², Hiroki TAKEMOTO¹, Atsumi NITTA^{1, 2} (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Department of Pharmaceutical Therapy and Neuropharmacology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan, 3. Laboratory of molecular pharmacology faculty of pharmaceutical sciences, University of Setsunan, Osaka, Japan)

^○Cynthia SIU¹, Mary Miu Yee WAYE², Shitao RAO^{2, 3, 4}, Marco Ho Bun LAM⁴, Ji-hui ZHANG⁴, Stephen Kwok Wing TSUI³, Yun Kwok WING⁴ (1. COS and Associates Ltd., Hong Kong SAR, China, 2. The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China, 3. School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China, 4. Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China)